Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

infant mortality

US infant mortality takes a turn for the worse

In calendar year 2022, annual infant mortality alarmingly rose in four states while receding to a reassuring degree in just one.

TAVR patients with cancer face higher risks of hospital readmission, serious bleeding

Short-term mortality, however, does not appear to change when TAVR patients present with active cancer. 

Lawrence Faucette, the pig heart transplant patient who died after six weeks.

Second patient in history to receive a pig heart transplant dies after 6 weeks

Lawrence Faucette, the second patient to ever receive a genetically modified pig heart, died on Oct. 30. “He can never be forgotten," his wife said in a statement. 

Thumbnail

IVL gains higher level of reimbursement with one of biggest coding updates for PCI in decades

Intravascular lithotripsy therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1.

audioplethysmography Google headphones

Google researchers use noise-canceling headphones to monitor heart health

The new technique, audioplethysmography, can monitor a user’s heart rate and other physiological signals using headphones equipped with active noice canceling technology. It requires no additional sensors.

df

‘More dangerous than useful’: 1 in 5 coronary stents implanted by cardiologists are unnecessary, wasting $800M per year

A cardiologist-led think tank tracked data from more than 1 million procedures, exploring the clinical and economic impacts of implanting low-value coronary stents. 

Robert Yeh, MD, explains the details of the AGENT IDE trial clinical trial results for the Agent drug-coated balloon vs plain angioplasty for in-stent restenosis at TCT 2023. #TCT #TCT2023 #DCB

Coronary drug-coated balloon superior to standard of care for in-stent restenosis

Robert Yeh, MD, detailed the importance of the pivotal AGENT IDE trial, which focused on the use of a paclitaxel-coated balloon to treat in-stent restenosis. 

Video of Michael Reardon, MD, explaining details from the Evolute Low Risk 4-year results at TCT 2023.

TAVR triumphs over surgery: Exploring 4-year data from the Evolut Low Risk trial

Michael Reardon, MD, discussed his team's late-breaking results at TCT 2023 in San Francisco.